Therapeutic Class
Bluebird wins US approval for world’s most expensive drug, Zynteglo
Therapeutic ClassBluebird wins US approval for world’s most expensive drug, ZyntegloBluebird wins US approval for world’s most expensive drug, Zynteglo
Zynteglo has a $2.8 million price tag, but bluebird says the gene therapy works out cheaper than current beta-thalassemia treatment options.